These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 38641088)

  • 21. The Gut Microbiota and Alzheimer's Disease.
    Jiang C; Li G; Huang P; Liu Z; Zhao B
    J Alzheimers Dis; 2017; 58(1):1-15. PubMed ID: 28372330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbial amyloids--functions and interactions within the host.
    Schwartz K; Boles BR
    Curr Opin Microbiol; 2013 Feb; 16(1):93-9. PubMed ID: 23313395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crosstalk Between Alpha-Synuclein and Other Human and Non-Human Amyloidogenic Proteins: Consequences for Amyloid Formation in Parkinson's Disease.
    Werner T; Horvath I; Wittung-Stafshede P
    J Parkinsons Dis; 2020; 10(3):819-830. PubMed ID: 32538869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional amyloids: interrelationship with other amyloids and therapeutic assessment to treat neurodegenerative diseases.
    Som Chaudhury S; Das Mukhopadhyay C
    Int J Neurosci; 2018 May; 128(5):449-463. PubMed ID: 29076790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer's Disease-a Critical Review.
    Sochocka M; Donskow-Łysoniewska K; Diniz BS; Kurpas D; Brzozowska E; Leszek J
    Mol Neurobiol; 2019 Mar; 56(3):1841-1851. PubMed ID: 29936690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gut-Brain Axis Deregulation and Its Possible Contribution to Neurodegenerative Disorders.
    Villavicencio-Tejo F; Olesen MA; Navarro L; Calisto N; Iribarren C; García K; Corsini G; Quintanilla RA
    Neurotox Res; 2023 Dec; 42(1):4. PubMed ID: 38103074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does the Gut Microbial Metabolome Really Matter? The Connection between GUT Metabolome and Neurological Disorders.
    Marć MA; Jastrząb R; Mytych J
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut Microbiota, Nitric Oxide, and Microglia as Prerequisites for Neurodegenerative Disorders.
    Tse JKY
    ACS Chem Neurosci; 2017 Jul; 8(7):1438-1447. PubMed ID: 28640632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PARK7/DJ-1 as a Therapeutic Target in Gut-Brain Axis Diseases.
    Pap D; Veres-Székely A; Szebeni B; Vannay Á
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The modulatory effect of plant polysaccharides on gut flora and the implication for neurodegenerative diseases from the perspective of the microbiota-gut-brain axis.
    Sun Q; Cheng L; Zeng X; Zhang X; Wu Z; Weng P
    Int J Biol Macromol; 2020 Dec; 164():1484-1492. PubMed ID: 32735929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effect of Gut Microbe Dysbiosis on the Pathogenesis of Alzheimer's Disease (AD) and Related Conditions.
    Nafady MH; Sayed ZS; Abdelkawy DA; Shebl ME; Elsayed RA; Ashraf GM; Perveen A; Attia MS; Bahbah EI
    Curr Alzheimer Res; 2022; 19(4):274-284. PubMed ID: 35440296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut power: Modulation of human amyloid formation by amyloidogenic proteins in the gastrointestinal tract.
    Wittung-Stafshede P
    Curr Opin Struct Biol; 2022 Feb; 72():33-38. PubMed ID: 34450484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders.
    Chen Y; Xu J; Chen Y
    Nutrients; 2021 Jun; 13(6):. PubMed ID: 34205336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What Are the Molecular Mechanisms by Which Functional Bacterial Amyloids Influence Amyloid Beta Deposition and Neuroinflammation in Neurodegenerative Disorders?
    Friedland RP; McMillan JD; Kurlawala Z
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of the Gut Microbiota and Microbial Metabolites in the Pathogenesis of Alzheimer's Disease.
    Wang Y
    CNS Neurol Disord Drug Targets; 2023; 22(4):577-598. PubMed ID: 35440320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysbiosis and Alzheimer's Disease: Cause or Treatment Opportunity?
    Janeiro MH; Ramírez MJ; Solas M
    Cell Mol Neurobiol; 2022 Mar; 42(2):377-387. PubMed ID: 33400081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modifying the diet and gut microbiota to prevent and manage neurodegenerative diseases.
    Gates EJ; Bernath AK; Klegeris A
    Rev Neurosci; 2022 Oct; 33(7):767-787. PubMed ID: 35304983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunity orchestrates a bridge in gut-brain axis of neurodegenerative diseases.
    Cheng Y; Chen C; Zhang F
    Ageing Res Rev; 2023 Mar; 85():101857. PubMed ID: 36669690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastrointestinal Dysfunction in Neurological and Neurodegenerative Disorders.
    Raber J; Sharpton TJ
    Semin Neurol; 2023 Aug; 43(4):634-644. PubMed ID: 37607587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do Bacterial Outer Membrane Vesicles Contribute to Chronic Inflammation in Parkinson's Disease?
    Koukoulis TF; Beauchamp LC; Kaparakis-Liaskos M; McQuade RM; Purnianto A; Finkelstein DI; Barnham KJ; Vella LJ
    J Parkinsons Dis; 2024; 14(2):227-244. PubMed ID: 38427502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.